AE
Arube Egbo
Credentials:
History
- 2026–2029
Residency
- 2022–2026
Medical School
Research
FDA approves Veozah (Fezolinetant) for menopausal symptoms: a new nonhormonal option
Letter or commentary · Annals of Medicine and Surgery · 2025 · 4 citations
1 paper · 1 as a resident